Second Sight Announces Underwriter Exercises Over-Allotment

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Second Sight Announces Underwriter Exercises Over-Allotment Option

SYLMAR, Calif., Nov. 24, 2014 (GLOBE NEWSWIRE) -- Second Sight Medical Products, Inc. (Nasdaq: EYES ) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics to restore some functional vision to blind patients, today announced that the underwriter for its initial public offering exercised its entire over-allotment option to purchase an additional 525,000 shares of the Company's common stock. The Company's shares of common stock are listed on The NASDAQ Market under the ticker symbol "EYES."

Total gross proceeds of Second Sight's initial public offering, including the over-allotment, were $36,225,000. Second Sight intends to use proceeds from the offering for general corporate purposes including:

  • promoting commercialization of its Argus II product;
  • research and development to enhance quality of vision in existing products; and,
  • research, development and clinical trials to expand the indications for use of the Argus II and its underlying intellectual property with the goal of treating nearly all currently untreatable cases of blindness (about eight million people globally).

MDB Capital Group acted as the sole underwriter for the offering.

Copies of the final prospectus can be obtained from: MDB Capital Group LLC, 401 Wilshire Blvd., Suite 1020, Santa Monica, CA 90401, (310) 526-5000.

A registration statement relating to these securities has been filed and declared effective by the U.S. Securities and Exchange Commission. This press release shall not constitute an offer to sell or the solicitation of an offer to buy any of the offered securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Second Sight Medical Products, Inc.

Second Sight develops, manufactures and markets implantable visual prosthetics to restore some functional vision to blind patients. The Company's current product is an advanced neurostimulation device called the Argus(R) II System, which treats retinitis pigmentosa. The Argus II System is the only retinal prosthesis approved in the United States by the Food and Drug Administration and the first approved retinal prosthesis in the world. The Company seeks to treat all blind patients through further improvements to their neurostimulation platform.

About MDB Capital Group

MDB Capital Group is Wall Street's only investment bank focused entirely on disruptive technology, with over 15 years of experience launching early stage technology companies into the public markets. MDB maximizes the value of disruptive technology companies by positioning them to attract growth capital, strengthening their patent portfolios to create sustainable competitive advantages, and connecting them with a base of high-quality investors committed to helping maximize the probability of the company's success. For more information, please visit www.mdb.com .

Safe Harbor Statement

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange and Exchange Act of 1934, as amended, that are intended to be covered by the "safe harbor" created by those sections. All statements in this release that are not based on historical fact are "forward looking statements". While management has based any forward looking statements included in this release on its current expectations, the information on which such expectations were based may change. Forward-looking statements involve inherent risks and uncertainties which could cause actual results to differ materially from those in the forward-looking statements, as a result of various factors including those risks and uncertainties described in the Risk Factors and in Management's Discussion and Analysis of Financial Condition and Results of Operations sections of our recently filed registration statement on Form S-1. We urge you to consider those risks and uncertainties in evaluating our forward-looking statements. We caution readers not to place undue reliance upon any such forward-looking statements, which speak only as of the date made. Except as otherwise required by the federal securities laws, we disclaim any obligation or undertaking to publicly release any updates or revisions to any forward-looking statement contained herein (or elsewhere) to reflect any change in our expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based.

Investor Relations Contacts: MZ North America Matt Hayden, Chairman T:949-259-4986 E: www.mzgroup.us In-Site Communications, Inc. Lisa Wilson, President T: 212-452-2793 E: Media: Pascale Communications, LLC Allison Potter, Manager of Professional Relations T: 412-228-1678 E:

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Rare Stellar Merger Validates RIT Theory in Nature

Updated Category News Views 62

One star swallowed another’s orbit, and astronomy finally caught the evidence. That is the plain-English punch of the observation called AT 2025abao in the Andromeda Galaxy, and it is a meaningful one for Jason Nordhaus and his colleagues at Rochester Institute of Technology. On Nov. 18, research published in Nature validated a scenario Nordhaus’s team had predicted...

Continue Reading
America's Group Adds Swansea to Its UK Auction Map

Updated Category News Views 128

A Welsh Lane Joins a Larger Road Port Talbot just became a small but telling dot on America's Group's international map. The company has acquired Swansea Motor Vehicle Auction Limited, a long-standing South Wales wholesale and remarketing operation, and plans to run it under the G3 brand. This is not the sort of deal that makes markets levitate. It is the sort that tells...

Continue Reading
Berlin Heals Puts Microcurrent Therapy to a Real Test

Updated Category News Views 56

A silent electrical signal is heading into the sort of trial that separates intriguing ideas from credible medical evidence. Berlin Heals Holding AG has initiated C-MIC IV, an international randomized, double-blind, sham-controlled study of its implanted microcurrent therapy for symptomatic heart failure. The first patient has already been implanted in Kragujevac, Serbia....

Continue Reading
ROHM's GaN PFC Chip Targets the Power-Supply Squeeze

Updated Category News Views 0

Power supplies are where a lot of sleek electronics quietly lose the plot, and ROHM is taking a proper swing at that problem. Its new BM85060FV is a totem-pole power factor correction controller built for gallium nitride, or GaN, high-frequency switching in AC-DC power supplies. The headline is not subtle: ROHM says a 300 to 500 W system using the chip can reach 99%...

Continue Reading
JOYY’s Ad Engine Gives Q3 Growth Some Real Teeth Now

Updated Category News Views 93

Three engines are finally pulling the cart at JOYY, and that is a far more interesting sight than another quarter of livestreaming merely holding together. The company reported third-quarter 2026 revenue of US$624.6 million, up 15.6% from a year earlier and 5.7% sequentially. Those are sturdy numbers, especially for a business that investors have long tended to box in as...

Continue Reading
Replit Bets on Trusted Creators to Sell AI Agents at Work

Updated Category News Views 52

Forty-five creators may sound like a marketing footnote, but Replit is aiming at a real enterprise bottleneck: people do not buy grand AI slogans; they buy proof that a messy internal problem can actually get fixed. Its newly launched Replit & Co. program puts business and technology creators in front of that problem, with product access, demonstrations and direct contact...

Continue Reading
Term or Whole Life: Costs, Coverage, and Trade-Offs

Updated Category News Views 56

A life insurance choice can sit quietly in a drawer for years, then become brutally important at exactly the wrong moment. Laura Wood's November 18, 2026 comparison of term and whole life insurance is useful for that reason: it keeps dragging the conversation back to the unglamorous stuff that actually matters—how long coverage lasts, what it costs, and whether a...

Continue Reading
OCEG Faces China's Demographic Test After 40 Years

Updated Category News Views 83

A school group that once opened 35 kindergartens in a year is admitting the old playbook has run its course. That is the real message behind Oriental Cambridge Education Group's 40th-anniversary talk, not the balloons and ceremonial language. OCEG operates more than 170 institutions across 39 Chinese cities, and its chairman, Yu Yue, says the next chapter will be judged...

Continue Reading
U.S. Patriot's Veteran Hiring Earns a Real National Nod

Updated Category News Views 58

A workforce award can be cheap wallpaper, but this one has some heft. U.S. Patriot, the veteran-founded and veteran-led military goods retailer owned by GALLS, landed on Military Times’ 2026 Best for Vets: Employers list, placing third in retail and first in Kentucky. The recognition covers 250 organizations, and this is U.S. Patriot’s fourth consecutive appearance....

Continue Reading
Italian Wine Faces U.S. Slump and New Market Openings

Updated Category News Views 133

American demand has put a cork in the easy story, and Italian wine producers cannot pretend otherwise. In the first nine months of 2026, U.S. imports of Italian wine dropped 18.4% by value. That is painful because the United States remains Italy's largest destination market by value, not some side shelf that can be ignored until conditions improve. Still, the broader U.S....

Continue Reading

Top 5 Most Recently Viewed Articles

Proaction Secures $4.2M to Challenge Legacy Fleet Firms

Updated Category News Views 129

Fleet Management: A Market Ripe for Disruption You ever cruised past an old clunker of a business model and thought, "Now there's a setup ripe for a rethink"? That's exactly what Proaction's up to with their recent $4.2 million cash injection. For anyone keeping tabs on the legacy fleet management scene, it’s like watching someone take a claw hammer to a creaky old...

Continue Reading
Mission Bio Unveils Groundbreaking Solution for Genome Analysis

Updated Category News Views 161

Mission Bio dropped the bomb back in 2024 with its Tapestri Genome Integrity CNV Solution, a serious piece of kit aimed at transforming how researchers tackle genomic integrity. This ain't just another offering; it’s the first single-cell high-throughput solution that measures genome-wide copy number variations (CNVs). Think of it as a lifeline for those deep in...

Continue Reading
Varonis Shines as a Leader in Data Security Platforms

Updated Category News Views 286

Varonis Receives Prestigious Recognition in Data Security Varonis Systems, Inc. (Nasdaq: VRNS) is excited to receive acknowledgment as a Leader within the data security landscape, as highlighted by a prominent research firm in their latest report. This recognition emphasizes Varonis’ commitment to securing data effectively while continuously evolving their platform to...

Continue Reading
CocoFest 2025: Embracing Community and Wellness Together

Updated Category News Views 497

CocoFest 2025: A Celebration of Community and Wellness CocoFest is returning for its third rendition, bringing together people for a day dedicated to celebrating love and wellness. This exciting event will take place on a Saturday at the Boca Raton Innovation Campus, showcasing how love can enhance our lives in various ways. What to Expect at CocoFest 2025 The festival...

Continue Reading
Innovative Speech Therapy Game Enhances Learning for Kids

Updated Category News Views 169

Innovative Speech Therapy Game Revolutionizes Learning In a vibrant city, an inventive mind has crafted a special game designed to make speech therapy more engaging for children. This game, known as LINGUA TOKENS, aims to bring excitement into learning fundamental speech skills. With a focus on fun, children aged 4 to 9 can enhance their articulation through play-based...

Continue Reading